Christopher Causey - Nov 2, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Nov 2, 2022
Transactions value $
-$559,299
Form type
4
Date filed
11/3/2022, 04:30 PM
Previous filing
Aug 25, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $439K +2.5K +88.18% $175.43 5.34K Nov 2, 2022 Direct F1
transaction UTHR Common Stock Sale -$600K -2.5K -46.86% $240.00 2.84K Nov 2, 2022 Direct F1
transaction UTHR Common Stock Options Exercise $439K +2.5K +88.18% $175.43 5.34K Nov 2, 2022 Direct F1
transaction UTHR Common Stock Sale -$625K -2.5K -46.86% $250.01* 2.84K Nov 2, 2022 Direct F1, F2
transaction UTHR Common Stock Options Exercise $439K +2.5K +88.18% $175.43 5.34K Nov 3, 2022 Direct F1
transaction UTHR Common Stock Sale -$650K -2.5K -46.86% $260.00 2.84K Nov 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -2.5K -21.74% $0.00 9K Nov 2, 2022 Common Stock 2.5K $175.43 Direct F1
transaction UTHR Stock Options Options Exercise $0 -2.5K -27.78% $0.00 6.5K Nov 2, 2022 Common Stock 2.5K $175.43 Direct F1
transaction UTHR Stock Options Options Exercise $0 -2.5K -38.46% $0.00 4K Nov 3, 2022 Common Stock 2.5K $175.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2 This transaction was executed in multiple trades at prices ranging from $250.00 to $250.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.